Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (21)

2024

  1. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340

2022

  1. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  2. IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy

    Kidney International Reports, Vol. 7, Núm. 4, pp. 831-840

  3. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. Consulta monográfica de onconefrología. Justificación y puesta en marcha

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 2, pp. 154-164

  2. Pre-emptive rituximab in focal and segmental glomerulosclerosis patients at risk of recurrence after kidney transplantation

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 139-148

  3. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

2011

  1. Chronic renal allograft damage: Existing challenges

    Transplantation, Vol. 91, Núm. 9 SUPPL.

2009

  1. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis

    Clinical Journal of the American Society of Nephrology, Vol. 4, Núm. 8, pp. 1317-1323